日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cost-Effectiveness of Perioperative Immune Checkpoint Therapy for NSCLC in Japan, the United States, and Brazil

日本、美国和巴西非小细胞肺癌围手术期免疫检查点疗法的成本效益分析

Fujioka, Masahiro; Aranishi, Toshihiko; Shukuya, Takehito; Araujo, Luiz; Owen, Dwight; Sowers, Tina; Shirai, Yukina; Carbone, David P; Takahashi, Kazuhisa

Current Status of Multimodal Therapy for Oligometastatic Disease, Induced Oligometastatic Disease, and Oligo-Progressive Disease in EGFR-Mutated Non-Small-Cell Lung Cancer

EGFR突变型非小细胞肺癌寡转移性疾病、诱导性寡转移性疾病和寡转移进展性疾病的多模式治疗现状

Miyawaki, Taichi; Kenmotsu, Hirotsugu; Ko, Ryo; Oshima, Masaki; Shukuya, Takehito; Shikama, Naoto; Takahashi, Kazuhisa

Spontaneous regression of tumors post-chemotherapy in a patient with relapsed small cell lung cancer: a case report

一例复发性小细胞肺癌患者化疗后肿瘤自发性消退:病例报告

Miyaki, Tomoha; Kataoka, Shunichi; Shukuya, Takehito; Yanai, Ayumi; Shiozaki, Hitomi; Motomura, Hiroaki; Miyawaki, Taichi; Hayashi, Takuo; Hattori, Aritoshi; Suzuki, Kenji; Takahashi, Kazuhisa

Development of a multimodal fully automated ensemble model to predict EGFR mutation and efficacy of EGFR-TKI in non-small cell lung cancer

开发一种多模态全自动集成模型,用于预测非小细胞肺癌中 EGFR 突变和 EGFR-TKI 的疗效

Xu, Shiting; Miyawaki, Taichi; Shukuya, Takehito; Suzuki, Kazuhiro; Shimamura, Shoko Sonobe; Matsuda, Hironari; Kanemaru, Ryota; Asao, Tetsuhiko; Mimori, Tomoyasu; Otsuka, Yujiro; Takahashi, Kazuhisa

Chest Tube Drainage, Bone Radiotherapy, and Brain Radiotherapy in Advanced Lung Cancer: A Retrospective Analysis of Associated Factors and Survival

晚期肺癌胸腔引流、骨放射治疗和脑放射治疗:相关因素和生存率的回顾性分析

Shimamura, Shoko Sonobe; Shukuya, Takehito; Takahashi, Kazuhisa; Shintani, Yasushi; Sekine, Ikuo; Takayama, Koichi; Inoue, Akira; Okamoto, Isamu; Kawaguchi, Tomoya; Yamamoto, Nobuyuki; Miyaoka, Etsuo; Yoshino, Ichiro; Date, Hiroshi

Intrapleural Administration of Hypotonic Cisplatin for Patients With Malignant Pleural Effusions and Non-Expandable Lungs

对恶性胸腔积液和肺不张患者进行胸膜内低渗顺铂注射

Mori, Wataru; Mimori, Tomoyasu; Ito, Jun; Sorimachi, Shun; Fujioka, Shinya; Hirakawa, Haruki; Masui, Yoshihiro; Miyawaki, Taichi; Shukuya, Takehito; Takahashi, Kazuhisa

Expert consensus on cancer treatment-related lung injury

关于癌症治疗相关肺损伤的专家共识

Lin, Xinqing; Guo, Hui; Zhao, Wei; Li, Min; Lin, Gen; Chu, Qian; Chen, Enguo; Chen, Liang'an; Chen, Rui; Chu, Tianqing; Deng, Haiyi; Deng, Yu; Dong, Hangming; Dong, Wen; Dong, Yuchao; Fang, Wenfeng; Gan, Xin; Gong, Liang; Gu, Yingying; Han, Qian; Hao, Yue; He, Yong; Hu, Chengping; Hu, Jie; Hu, Yi; Jiang, Yongliang; Jin, Yang; Lan, Fen; Li, Weimin; Li, Weifeng; Liang, Wenhua; Liu, Anwen; Liu, Dan; Liu, Ming; Liu, Mengjie; Liu, Zhuo; Liu, Zhefeng; Luo, Qun; Miao, Liyun; Mu, Chuanyong; Pan, Pinhua; Peng, Ping; Qin, Jianwen; Qin, Yinyin; Shen, Panxiao; Shi, Minhua; Song, Yong; Su, Chunxia; Su, Jin; Su, Xin; Tan, Xiaowu; Tang, Kejing; Tang, Xiaomei; Tian, Panwen; Wang, Binchao; Wang, Huijuan; Wang, Kai; Wang, Mengzhao; Wang, Qi; Wang, Wenxian; Wang, Zhijie; Wu, Di; Xu, Fei; Xu, Yan; Xu, Chunwei; Xie, Zhanhong; Xie, Xiaohong; Yang, Boyan; Yang, Meng; Ye, Feng; Ye, Xiaoqun; Yu, Zongyang; Zhang, Jian; Zhang, Jianqing; Zhang, Xiaoju; Zhao, Fei; Zheng, Xiaobin; Zhu, Bo; Zhu, Zhengfei; Zhou, Jianya; Zhou, Jianying; Zhou, Min; Zhou, Qing; Zou, Zihua; Kidane, Biniam; Bignami, Elena; Sakamaki, Fumio; Roviello, Giandomenico; Taniguchi, Hirokazu; Jeon, Kyeongman; Saric, Lenko; Ariza-Prota, Miguel; La-Beck, Ninh M; Kanaji, Nobuhiro; Watanabe, Satoshi; Shukuya, Takehito; Akaba, Tomohiro; Leong, Tracy L; Gesierich, Wolfgang; Koga, Yasuhiko; Tanino, Yoshinori; Uehara, Yuji; Li, Shiyue; Chen, Rongchang; Zhou, Chengzhi

Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial

阿特珠单抗联合铂类药物加培美曲塞,加或不加贝伐珠单抗治疗转移性非鳞状非小细胞肺癌:一项3期随机临床试验

Shiraishi, Yoshimasa; Kishimoto, Junji; Sugawara, Shunichi; Mizutani, Hideaki; Daga, Haruko; Azuma, Koichi; Matsumoto, Hirotaka; Hataji, Osamu; Nishino, Kazumi; Mori, Masahide; Shukuya, Takehito; Saito, Haruhiro; Tachihara, Motoko; Hayashi, Hidetoshi; Tsuya, Asuka; Wakuda, Kazushige; Yanagitani, Noriko; Sakamoto, Tomohiro; Miura, Satoru; Hata, Akito; Okada, Morihito; Kozuki, Toshiyuki; Sato, Yuki; Harada, Taishi; Takayama, Koichi; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko; Okamoto, Isamu

Impact of Cachexia and First-Line Systemic Therapy for Previously Untreated Advanced Non-Small Cell Lung Cancer: NEJ050A

恶病质和一线全身治疗对既往未接受治疗的晚期非小细胞肺癌的影响:NEJ050A

Miura, Keita; Shukuya, Takehito; Furuya, Naoki; Morita, Ryo; Kisohara, Akira; Mouri, Atsuto; Watanabe, Satoshi; Tanaka, Hisashi; Hirata, Aya; Hakozaki, Taiki; Hamai, Kosuke; Matsumoto, Naoko; Watanabe, Kana; Ashinuma, Hironori; Miyauchi, Eisaku; Sugano, Koji; Hosokawa, Shinobu; Amano, Koji; Morita, Satoshi; Kobayashi, Kunihiko; Maemonodo, Makoto; Takahashi, Kazuhisa

Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapy

分子靶向药物和免疫疗法出现后,晚期或复发性非小细胞肺癌患者发生第二原发性恶性肿瘤的风险增加。

Masui, Yoshihiro; Shukuya, Takehito; Kataoka, Shunichi; Shiozaki, Hitomi; Kurokawa, Kana; Nakamura, Ikuko; Miyawaki, Taichi; Koinuma, Yoshika; Asao, Tetsuhiko; Kanemaru, Ryota; Shimamura, Shoko Sonobe; Mimori, Tomoyasu; Mitsuishi, Yoichiro; Tajima, Ken; Shimada, Naoko; Takahashi, Kazuhisa